Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Leitao

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|February 22, 2002
Preoperative CA-125 levels in patients with hereditary compared to sporadic epithelial ovarian carcinomaMario Leitao, Jeff Boyd
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2025
Uterine transposition for fertility preservation in pelvic cancersReitan Ribeiro, Glauco Baiocchi, Andreas Obermair, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2024
Uterine transposition for fertility preservation in pelvic cancersReitan Ribeiro, Glauco Baiocchi, Andreas Obermair, et al.
Gynecologic Oncology|December 8, 2004
Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasmsYun Wu, Robert A Soslow, David S Marshall, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 11, 2003
Melan-A (A103) and inhibin expression in ovarian neoplasmsDavis X Yao, Robert A Soslow, Cyrus V Hedvat, et al.
Obstetrics and Gynecology|October 24, 2012
Management of endometrial precancersCornelia L Trimble, Michael Method, Mario Leitao, et al.
Gynecologic Oncology|July 29, 2008
What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?Nadeem R Abu-Rustum, Dennis S Chi, Mario Leitao, et al.
Cancer|October 30, 2013
Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology GroupJubilee Brown, William E Brady, Julian Schink, et al.
Annals of Surgical Oncology|March 13, 2014
Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancerShari Damast, Kaled Alektiar, Anne Eaton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2020
Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterusMichaela Onstad, Jennifer Ducie, Bryan M Fellman, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|February 22, 2002
Preoperative CA-125 levels in patients with hereditary compared to sporadic epithelial ovarian carcinomaMario Leitao, Jeff Boyd
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2025
Uterine transposition for fertility preservation in pelvic cancersReitan Ribeiro, Glauco Baiocchi, Andreas Obermair, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2024
Uterine transposition for fertility preservation in pelvic cancersReitan Ribeiro, Glauco Baiocchi, Andreas Obermair, et al.
Gynecologic Oncology|December 8, 2004
Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasmsYun Wu, Robert A Soslow, David S Marshall, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 11, 2003
Melan-A (A103) and inhibin expression in ovarian neoplasmsDavis X Yao, Robert A Soslow, Cyrus V Hedvat, et al.
Obstetrics and Gynecology|October 24, 2012
Management of endometrial precancersCornelia L Trimble, Michael Method, Mario Leitao, et al.
Gynecologic Oncology|July 29, 2008
What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?Nadeem R Abu-Rustum, Dennis S Chi, Mario Leitao, et al.
Cancer|October 30, 2013
Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology GroupJubilee Brown, William E Brady, Julian Schink, et al.
Annals of Surgical Oncology|March 13, 2014
Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancerShari Damast, Kaled Alektiar, Anne Eaton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2020
Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterusMichaela Onstad, Jennifer Ducie, Bryan M Fellman, et al.
Pageof 3